Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 410

Results For "SPE"

4981 News Found

LifeCell India initiative to identify breast cancer risk in women
Healthcare | March 08, 2022

LifeCell India initiative to identify breast cancer risk in women

The revolutionary genetic test helps screen common genes associated with hereditary breast and ovarian cancer in women above 18 years of age


American Oncology Institute highlights spirit of women cancer survivors
Healthcare | March 08, 2022

American Oncology Institute highlights spirit of women cancer survivors

AOI is the leading cancer hospital chain of South Asia operating 16 cancer hospitals in the region


GOQii survey points to rise in women medical issues
Public Health | March 08, 2022

GOQii survey points to rise in women medical issues

Women's health is in fact a direct reflection of the nation's overall health


Toyobo invests in US-based biotech startup DMC Biotechnologies
Startup | March 08, 2022

Toyobo invests in US-based biotech startup DMC Biotechnologies

Toyobo will start looking at ways to use the knowhow from DMC’s sophisticated fermentation process technologies to enhance the efficiency of making its bioproducts


Lonza completes expansion of API manufacturing Lab in Nansha, China
News | March 08, 2022

Lonza completes expansion of API manufacturing Lab in Nansha, China

The expansion is part of Lonza’s continued investment in its global manufacturing network, aiming to build a comprehensive offering for global customers


Cionic’s Neural Sleeve granted USFDA clearance
Medical Device | March 08, 2022

Cionic’s Neural Sleeve granted USFDA clearance

Neural sleeve first algorithm-powered bionic garment designed to help those with mobility issues due to multiple sclerosis, stroke, cerebral palsy, and other conditions, regain functional movement in everyday activities


IOL Chemicals and Pharmaceuticals to limit capex at Rs 150 crore per year
News | March 07, 2022

IOL Chemicals and Pharmaceuticals to limit capex at Rs 150 crore per year

The company already has the world’s largest capacity for ibuprofen and is now looking at expansion in new molecules as the idea is to actually de-risk the business


Zydus’ OxemiaTM receives approval from DCGI to treat Anaemia associated with Chronic Kidney Disease
Drug Approval | March 07, 2022

Zydus’ OxemiaTM receives approval from DCGI to treat Anaemia associated with Chronic Kidney Disease

OxemiaTM (Desidustat) is an oral tablet formulation that is the first-in-India alternative to injectable erythropoietin-stimulating agents (ESAs)


Jardiance is first and only treatment approved in Europe for chronic heart failure
Drug Approval | March 07, 2022

Jardiance is first and only treatment approved in Europe for chronic heart failure

The breakthrough approval expands the existing indication of Jardiance to include adults with heart failure with preserved ejection fraction (HFpEF), an underserved patient population that previously had no approved therapies in Europe


AstraZeneca flags off ‘AZ Forest’ a mass sapling plantation campaign in Bengaluru
Sustainability | March 07, 2022

AstraZeneca flags off ‘AZ Forest’ a mass sapling plantation campaign in Bengaluru

Commits to plant 5000 trees in phase 1 with its partner SankalpTaru Foundation